期刊文献+

光动力疗法治疗年龄相关性黄斑变性短期内的多焦视网膜电图变化 被引量:2

Short term changes in multifocal electroretinogram after photodynamic therapy for age-related macular degeneration
下载PDF
导出
摘要 目的应用多焦视网膜电图评价渗出型年龄相关性黄斑变性患者光动力疗法(photodynamic therapy,PDT)治疗后视网膜功能的改变。方法对18例(20眼)渗出型年龄相关性黄斑变性患者在PDT治疗前,及治疗后7d^3个月分别进行视力、mfERG、FFA、OCT、ICGA的检查。应用重复测量方差分析比较mfERG N1、P1波振幅密度变化。结果在显著经典型脉络膜新生血管(choroidal neovascularization,CNV)组所有8例(8眼)患者术后视力均提高或稳定,PDT治疗后7d的mfERG N1波、P1波振幅密度与治疗前比较均无明显差异(P>0.05),但治疗后45d和3个月时mfERG1~5环N1波、P1波振幅密度值比治疗前均有提高(P<0·05),且治疗后3个月时mfERG1~4环N1、P1波振幅密度值较45d时有所降低;轻微经典型CNV组视力提高、稳定或下降,各期mfERG N1、P1波振幅密度与治疗前比较均无明显差异(P>0.05);2组治疗前后各期mfERG N1、P1波潜伏期时值均无明显差异(P>0.05)。结论PDT疗法可以稳定显著经典型CNV组患眼视力,mfERG显示它还能改善黄斑部的功能,mfERG能为脉络膜新生血管患者的视网膜功能提供有效的评价。 Objective To assess the changes of retinal function of patients with age-related macular degeneration ( AMD ) after photodynamic therapy (PDT) by multifocal electroretinogram (mfERG). Methods The visual acuity, mfERG, optical coherence tomography (OCT) and fundus fluorescein angiography(FFA) were detected in eighteen patients (20 eyes) with AMD before and 7 days to 3 months after PDT. The changes of mfERG N1 and P1 wave peak amplitude densities were analyzed with repeated measurement analysis of variance. Results In the predominantly classical choroidal neovascular membrane group, visual acuity remained stable or improved in 8 patients(8 eyes);N1 and P1 wave peak amplitudes densities in the ring 1-6 did not change significantly 7 days after treatment (P 〉0.05), but they were improved in ring 1-5 45 days and 3 months after treatment (P 〈 0.05) ; N1 and P1 wave peak amplitudes densities in the ring 1-4 were decreased from 45 days to 3 months after PDT (P 〈 0.05). In the minimally classic choroldal neovascular membrane group, visual acuity remained stable or improved or decreased; N1 and P1 wave peak amplitudes densities in the ring 1- 6 did not change significantly at different period (P 〉0.05). In two groups, N1 and P1 wave peak latency did not change significantly at different period before and after treatment ( P 〉 0.05 ). Conclusion PDT can lead to stabilization of visual acuity in patients with a predominantly classic chorotdal neovascular membrane. Improvement in macular function can be demonstrated in mf-ERG recordings. The mf-ERG may be helpful for the assessment of retinal function of patients with choroidal neovascular membrane.
出处 《眼科新进展》 CAS 2006年第9期681-684,共4页 Recent Advances in Ophthalmology
关键词 年龄相关性黄斑变性 脉络膜新生血管 光动力疗法 多焦视网膜电图 age-related macular degeneration choroidal neovascularization photodynamic therapy multifocal electroretinogram
  • 相关文献

参考文献7

  • 1Catala-Mora J,Castany-Aregall M,Berniell-Trota JA,Arias-Barquet L,Roca-Linares G,Jurgens-Mestre I.Multifocal electroretinogram and age-related macular degeneration[J].Arch Soc Esp Oftalmol 2005;80(7):395-404. 被引量:1
  • 2姜利斌,金陈进,吴乐正,文峰,黄时洲,吴德正.光动力疗法治疗脉络膜新生血管性疾病的多焦视网膜电图改变[J].中国实用眼科杂志,2004,22(8):607-610. 被引量:3
  • 3Verteporfin in photodynamic therapy (VIP) study group.Verteporfin therapy of subfoveal choroidal neovascularization in age related macular degeneration:two-year results of radomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin photodynamic therapy report 2[J].Am J Ophthalmol 2001;131(5):541-560. 被引量:1
  • 4Husain D,Miller JW,Michaud N,Michaud N,Connolly E,Flotte TJ,et al.Intravenous infusion of liosomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization[J].Arch Ophthalmol 1996;114(8):978-985. 被引量:1
  • 5Palmowski AM,Allgayer R,Heinemann-Vemaleken B,Ruprecht KW.Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry[J].Ophthalmology 2002;109(10):1788-1792 被引量:1
  • 6Schmidt-Erfurth U,Miller JW,Sickenberg M,Bunse A,Laqua H,Gragoudas E,et al.Photodynamic therapy of subfoveal choroidal neovascularization:clinical and angiographic examples[J].Graefe Arch Clin Esp Ophthalmol 1998;236(5):365-374. 被引量:1
  • 7Miller JW,Schmidt-Erfurth U,Sickenberg M,Pouruaras CJ,Laqua H,Barbazetto I,et al.Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration:results of a single treatment in a phase 1 and 2 study[J].Arch Ophthalmol 1999;117(9):1161-1173. 被引量:1

二级参考文献9

  • 1Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age - related macular degeneration: two - year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - - verteporfin in photodynamic therapy report 2. Am J Ophthalmol,2001, 131:541-560. 被引量:1
  • 2Sickenberg, M; Schmidt-Erfurth, U; Miller, JW, et al, A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol,2000, 118:327-336. 被引量:1
  • 3Husain D, Kramer M, Kenny AG, et al. Effect of photodynamic therapy using verteporfin of experimental choruidal neovascularization and normal retinal and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci, 1999, 40:2322-2331. 被引量:1
  • 4Kramer M, Miller JW, Michaud N, et al, Liposomal BPD verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology, 1996, 103:427-438. 被引量:1
  • 5Husain D, Miller JW, Michaud N, et al, Intravenous infusion usingliposomal BPD verteporfin for photodynamic therapy of experimental choroidal neovascularization, Arch Ophthalmol, 1996, 114:978-985. 被引量:1
  • 6Haimovicl R, Kramer M, Miller JW, et al, Localization of lipoprotein- delivered benzoporphyrin derivative in the rabbit eye, Curr Eye Res, 1997, 16:83-90. 被引量:1
  • 7Schnurrbusch UE, Welt K, Horn LC, et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. BrJ Ophthalmol, 2001, 85:1086-1091. 被引量:1
  • 8Bearse MA, Sutter EE. Imaging local retinal dysfuction with the multifocal electroretinogram. J Opt Soc Am, 1996, 13:634-640. 被引量:1
  • 9Seerliger M, Kretschmann U, Apfelstedt-Sylla E, et al. Multifocal electroretinograghy in retinitis pigmentosa. Am J Ophthalmol, 1998,125:214-226. 被引量:1

共引文献2

同被引文献15

  • 1Salomon Y. Cohen , Sylvia Nghiem-Buffet , Typhaine Grenet, et al. Long-termvariable outcome of myopic choroidal neovascularization treated with ranibizumab. Jap J Ophthalmol,2015 ,59 :36-42. 被引量:1
  • 2Hae Min Kang , Hyoung Jun Koh. Intravitreal anti - vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol, 2013, 155:713-719. 被引量:1
  • 3Cristina Calvo-Gonzalez,Juan Reche-Frutos, Juan Donate, et al. Intravitreal Ranibizumab for Myopic Choroidal Neovascularization : Factors Predictive of Visual Outcome and Need for Retreatment. Am J Ophthalmol,2011,151:529-534. 被引量:1
  • 4Xiaoxin Li ,C, ezhi Xu ,Yusheng Wang, et at. Safety and efficacy of Conbercept in neovascular age-related macular degeneration:Result from a 12-month randomized phase 2 study: Aurora study. Ophthamology,2014,121:1740-1747. 被引量:1
  • 5Soubrane G . Choroidal neovascularization in pathologic myopia: Recent developments in diagnosis and treatment. Surv Ophthalmol, 2008,53:121-138. 被引量:1
  • 6Philip J, Rosenfeld, J effery S, et al. Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovasclar Age-Related Macular Degeneration. Ophthalmology, 2006, 113:623-632. 被引量:1
  • 7Sliva RM, Ruiz-Moreno JM, Nascimento J, et al. Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retia,2008,28 : 1117-1123. 被引量:1
  • 8Dong Min Cha, Tae Wan Kim, Jang Won Heo, et al. Comparsion of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularizafion : a retrospective, multicenter, comparative study. BMC Ophthalmol,2014,14:69. 被引量:1
  • 9Fumi Gomi, Kentaro Nishida, Yusuke Oshima, et al. lntravitreal Bevacizumab for Idiopathic Choroidal Neovascularization after Previous Injection with Posterior Subtenon Triamcinolone. Am J Ophthalmo1,2007,143:507-509. 被引量:1
  • 10Yi-Hsuan Li, Cheng-Kuo Cheng, Yu-Tang Tseng. Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients inTaiwan. Taiwan Journal of Ophthalmology,2015,5:76-84. 被引量:1

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部